INTRODUCTION: Retrospective research suggests smokers with posttraumatic stress disorder (PTSD) lapse more quickly after their quit date. Ecological momentary assessment (EMA) research is needed to confirm the presence of early smoking lapse in PTSD and form conceptualizations that inform intervention. METHODS: Smokers with (n = 55) and without (n = 52) PTSD completed alarm-prompted EMA of situational and psychiatric variables the week before and after a quit date, and self-initiated EMA following smoking lapses. Blood samples at baseline and on the quit date allowed assessment of dehydroepiandrosterone (DHEA) and dehydroepiandrosterone sulfate (DHEA(S)). RESULTS: PTSD was related to shorter time to lapse (hazard ratio [HR] = 1.677, 95% CI: 1.106-2.544). Increased smoking abstinence self-efficacy was related to longer time to lapse (HR = 0.608, 95% CI: 0.430-0.860). Analyses of participants' real-time reports revealed that smokers with PTSD were more likely to attribute first-time lapses to negative affect ( = 5.412, p = .020), and trauma reminders (Fisher's exact p = .003**). Finally, the quit date decrease in DHEA(S) was related to shorter time to lapse (HR = 1.009, 95% CI: 1.000-1.018, p < .05). CONCLUSIONS: Results provide evidence of shorter time to first smoking lapse in PTSD, and add to evidence that early lapse occasions are more strongly related to trauma reminders, negative affect, and cravings in smokers with PTSD.
INTRODUCTION: Retrospective research suggests smokers with posttraumatic stress disorder (PTSD) lapse more quickly after their quit date. Ecological momentary assessment (EMA) research is needed to confirm the presence of early smoking lapse in PTSD and form conceptualizations that inform intervention. METHODS: Smokers with (n = 55) and without (n = 52) PTSD completed alarm-prompted EMA of situational and psychiatric variables the week before and after a quit date, and self-initiated EMA following smoking lapses. Blood samples at baseline and on the quit date allowed assessment of dehydroepiandrosterone (DHEA) and dehydroepiandrosterone sulfate (DHEA(S)). RESULTS:PTSD was related to shorter time to lapse (hazard ratio [HR] = 1.677, 95% CI: 1.106-2.544). Increased smoking abstinence self-efficacy was related to longer time to lapse (HR = 0.608, 95% CI: 0.430-0.860). Analyses of participants' real-time reports revealed that smokers with PTSD were more likely to attribute first-time lapses to negative affect ( = 5.412, p = .020), and trauma reminders (Fisher's exact p = .003**). Finally, the quit date decrease in DHEA(S) was related to shorter time to lapse (HR = 1.009, 95% CI: 1.000-1.018, p < .05). CONCLUSIONS: Results provide evidence of shorter time to first smoking lapse in PTSD, and add to evidence that early lapse occasions are more strongly related to trauma reminders, negative affect, and cravings in smokers with PTSD.
Authors: S Shiffman; M H Balabanis; J A Paty; J Engberg; C J Gwaltney; K S Liu; M Gnys; M Hickcox; S M Paton Journal: Health Psychol Date: 2000-07 Impact factor: 4.267
Authors: C J Gwaltney; S Shiffman; G J Norman; J A Paty; J D Kassel; M Gnys; M Hickcox; A Waters; M Balabanis Journal: J Consult Clin Psychol Date: 2001-06
Authors: Thomas M Piasecki; Douglas E Jorenby; Stevens S Smith; Michael C Fiore; Timothy B Baker Journal: Exp Clin Psychopharmacol Date: 2003-11 Impact factor: 3.157
Authors: Eric A Dedert; Patrick S Calhoun; Leia A Harper; Courtney E Dutton; Francis Joseph McClernon; Jean C Beckham Journal: Nicotine Tob Res Date: 2011-10-24 Impact factor: 4.244
Authors: Ann M Rasmusson; Jitka Vasek; Deborah S Lipschitz; Dolores Vojvoda; Mary Ellen Mustone; Quihu Shi; Gretchen Gudmundsen; Charles A Morgan; Jessica Wolfe; Dennis S Charney Journal: Neuropsychopharmacology Date: 2004-08 Impact factor: 7.853
Authors: A C Kirby; B P Hertzberg; C F Collie; B Yeatts; M F Dennis; S D McDonald; P S Calhoun; J C Beckham Journal: Addict Behav Date: 2008-05-22 Impact factor: 3.913
Authors: Eric A Dedert; Paul A Dennis; Cindy M Swinkels; Patrick S Calhoun; Michelle F Dennis; Jean C Beckham Journal: Nicotine Tob Res Date: 2013-11-05 Impact factor: 4.244
Authors: Angela R Volz; Paul A Dennis; Michelle F Dennis; Patrick S Calhoun; Sarah M Wilson; Jean C Beckham Journal: Nicotine Tob Res Date: 2014-01-28 Impact factor: 4.244
Authors: Scott R Vrana; Patrick S Calhoun; Michelle F Dennis; Angela C Kirby; Jean C Beckham Journal: J Psychopharmacol Date: 2015-08-07 Impact factor: 4.153